AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
Our Story
We are united in purpose
At AlloVir, we are pioneering science in the field of virus-specific T cell (VST) therapies in our mission to prevent and defeat life-threatening viral diseases.
Our approach involves the restoration of viral immunity through the adoptive transfer of VSTs that have been prospectively generated from healthy, eligible donors and are available on demand for off-the-shelf therapy.
We embrace a shared commitment to creating a future with immunity for all.
Our approach involves the restoration of viral immunity through the adoptive transfer of VSTs that have been prospectively generated from healthy, eligible donors and are available on demand for off-the-shelf therapy.
We embrace a shared commitment to creating a future with immunity for all.
We challenge the status quo
We champion truth and challenge the status quo in pursuit of continuous improvement in the fight against viral diseases. Our innovative spirit lives beyond the lab, creating a world where everyone has access to a healthy immune system.